Adhita Biosciences Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.15 M
- Company Age 9 Year, 3 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 1.20 M
- Satisfied Charges ₹ 0.28 M
- Revenue Growth %
- Profit Growth 383.57%
- Ebitda 1383.37%
- Net Worth 66.00%
- Total Assets 514.57%
About Adhita Biosciences
Adhita Biosciences Private Limited (ABPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 30 October 2015 (Nine years and three months 18 days old ). Its registered office is in Lucknow, Uttar Pradesh, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.15 M.
The company currently has active open charges totaling ₹1.20 M. The company has closed loans amounting to ₹0.28 M, as per Ministry of Corporate Affairs (MCA) records.
Nishi Morya and Rahul Maurya serve as directors at the Company.
Company Details
-
Location
Lucknow, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U74120UP2015PTC074195
-
Company No.
074195
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
30 Oct 2015
-
Date of AGM
29 Nov 2021
-
Date of Balance Sheet
31 Mar 2021
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Adhita Biosciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nishi Morya
|
Director | 01-Mar-2021 | Current |
|
Rahul Maurya
|
Director | 05-Nov-2020 | Current |
Financial Performance of Adhita Biosciences.
Adhita Biosciences Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 383.57% increase in profit. The company's net worth Soared by an impressive increase of 66%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Adhita Biosciences?
In 2017, Adhita Biosciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Adhita Food And Beverages Private LimitedRahul Maurya is a mutual person
Charges (Loans)
₹1.20 M
₹0.28 M
Charges Breakdown by Lending Institutions
- Others : 0.12 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Mar 2020 | Others | ₹1.20 M | Open |
| 04 Mar 2020 | Others | ₹0.28 M | Satisfied |
How Many Employees Work at Adhita Biosciences?
Unlock and access historical data on people associated with Adhita Biosciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Adhita Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Adhita Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
